265 related articles for article (PubMed ID: 38597637)
1. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
3. Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia.
Claassens M; Dreyer V; Nepolo E; Mokomele Q; van Rooyen G; Ruswa N; Günther G; Niemann S
Microbiol Spectr; 2022 Oct; 10(5):e0158622. PubMed ID: 36165641
[TBL] [Abstract][Full Text] [Related]
4. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
[TBL] [Abstract][Full Text] [Related]
5. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal.
Cohen KA; Abeel T; Manson McGuire A; Desjardins CA; Munsamy V; Shea TP; Walker BJ; Bantubani N; Almeida DV; Alvarado L; Chapman SB; Mvelase NR; Duffy EY; Fitzgerald MG; Govender P; Gujja S; Hamilton S; Howarth C; Larimer JD; Maharaj K; Pearson MD; Priest ME; Zeng Q; Padayatchi N; Grosset J; Young SK; Wortman J; Mlisana KP; O'Donnell MR; Birren BW; Bishai WR; Pym AS; Earl AM
PLoS Med; 2015 Sep; 12(9):e1001880. PubMed ID: 26418737
[TBL] [Abstract][Full Text] [Related]
7. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
9. Whole genome sequencing of drug resistant Mycobacterium tuberculosis isolates from a high burden tuberculosis region of North West Pakistan.
Jabbar A; Phelan JE; de Sessions PF; Khan TA; Rahman H; Khan SN; Cantillon DM; Wildner LM; Ali S; Campino S; Waddell SJ; Clark TG
Sci Rep; 2019 Oct; 9(1):14996. PubMed ID: 31628383
[TBL] [Abstract][Full Text] [Related]
10. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
11. Emergence of bedaquiline-resistant tuberculosis and of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains with rpoB Ile491Phe mutation not detected by Xpert MTB/RIF in Mozambique: a retrospective observational study.
Barilar I; Fernando T; Utpatel C; Abujate C; Madeira CM; José B; Mutaquiha C; Kranzer K; Niemann T; Ismael N; de Araujo L; Wirth T; Niemann S; Viegas S
Lancet Infect Dis; 2024 Mar; 24(3):297-307. PubMed ID: 37956677
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
[TBL] [Abstract][Full Text] [Related]
13. Drug-resistant Mycobacterium tuberculosis among Nepalese patients at a tuberculosis referral center.
Chand AB; Basnet A; Maharjan B; Rai G; Joshi YP; Bhatt LR; Sen B; Rai SK
PLoS One; 2024; 19(5):e0301210. PubMed ID: 38709710
[TBL] [Abstract][Full Text] [Related]
14. Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.
Matsui T; Pinhata JMW; Rabello MCDS; Brandão AP; Ferrazoli L; Leão SC; Viana-Niero C; Oliveira RS
Mem Inst Oswaldo Cruz; 2020; 115():e200055. PubMed ID: 32401997
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa.
Olawoye IB; Uwanibe JN; Kunle-Ope CN; Davies-Bolorunduro OF; Abiodun TA; Audu RA; Salako BL; Happi CT
Sci Rep; 2021 Aug; 11(1):17387. PubMed ID: 34462504
[TBL] [Abstract][Full Text] [Related]
16. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing for Characterizing Drug Resistance-Conferring Mycobacterium tuberculosis Genes from Clinical Isolates in the Ukraine.
Daum LT; Konstantynovska OS; Solodiankin OS; Liashenko OO; Poteiko PI; Bolotin VI; Hrek II; Rohozhyn AV; Rodriguez JD; Fischer GW; Chambers JP; Gerilovych AP
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563202
[TBL] [Abstract][Full Text] [Related]
18. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome sequencing of
Wang L; Yang J; Chen L; Wang W; Yu F; Xiong H
Epidemiol Infect; 2022 Jan; 150():e22. PubMed ID: 35086603
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of drug resistance-associated mutations among clinical multidrug-resistant Mycobacterium tuberculosis isolates from Hebei Province, China.
Li Q; Wang Y; Li Y; Gao H; Zhang Z; Feng F; Dai E
J Glob Antimicrob Resist; 2019 Sep; 18():168-176. PubMed ID: 30926465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]